Polymeric biomaterials derived from monomers comprising hydroxyacids and phenol compounds and their medical uses
US-2015045451-A1 · Feb 12, 2015 · US
US10774030B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10774030-B2 |
| Application number | US-201616065889-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 3, 2016 |
| Priority date | Dec 23, 2014 |
| Publication date | Sep 15, 2020 |
| Grant date | Sep 15, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are new classes of diphenol compounds, derived from tyrosol or tyrosol analogues and hydroxybenzoic acid, which are useful as monomers for preparation of biocompatible polymers. Also disclosed are biocompatible polymers prepared from these monomeric diphenol compounds, including novel biodegradable and/or bioresorbable polymers of formula. These biocompatible polymers or polymer compositions with enhanced bioresorbability and processibility are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic compositions. The invention also provides methods for preparing these monomeric diphenol compounds and biocompatible polymers.
Opening claim text (preview).
What is claimed is: 1. A biocompatible polymer, comprising a recurring unit of formula: wherein: j and k are each independently zero or an integer selected from 1 to 6, provided that j and k are not both 0; X 1 and X 2 are each independently bromine (Br) or iodine (I), and y 1 and y 2 are each independently 0, 1, 2, 3, or 4; L 1 is selected from the group consisting of oxygen (—O—), —R 4 —C(═O)—O—, and —O—R 4a —O—C(═O)—; wherein R 4 is selected from the group consisting of C 1 -C 30 alkylene, C 2 -C 30 alkenylene, C 2 -C 30 alkynylene, C 1 -C 30 heteroalkylene, C 2 -C 30 heteroalkenylene, C 2 -C 30 heteroalkynylene, C 6 -C 30 arylene, C 7 -C 30 alkylarylene, C 8 -C 30 alkenylarylene, C 8 -C 30 alkynylarylene, and C 2 -C 30 heteroarylene; and R 4a is selected from the group consisting of C 1 -C 30 alkylene, C 2 -C 30 alkenylene, C 2 -C 30 alkynylene, C 1 -C 30 heteroalkylene, C 2 -C 30 heteroalkenylene, C 2 -C 30 heteroalkynylene, C 6 -C 30 arylene, C 7 -C 30 alkylarylene, C 8 -C 30 alkenylarylene, C 8 -C 30 alkynylarylene, and C 2 -C 30 heteroarylene; L 4 is selected from the group consisting of a bond, and optionally substituted phenoxy (C 6 H 4 —O—); L 5 is a bond; Q 2 at each occurrence is independently hydrogen or halogen; or two adjacent Q 2 form a double bond when adjacent Qs are present; or Z 2 and an adjacent Q 2 form a double bond; Z 2 is hydrogen, —N(R x )C(═O)R 5 , —N(R x )COOR 6 , —C(O)OR 7 or —C(O)NR x R y , or Z 2 and an adjacent Q 2 form a double bond; wherein R 5 , R 6 , R 7 , R x and R y are independently at each occurrence selected from the group consisting of hydrogen, alkyl, aryl, alkylaryl, arylalkyl, heteroalkyl, and heteroalkylaryl, wherein the non-hydrogen groups contain up to 30 carbon atoms, wherein the heteroalkyl group contains from 1 to 10 heteroatoms independently selected from O, N and S, and the heteroalkylaryl group contains from 1 to 3 heteroatoms independently selected from O, N and S; and wherein A 1 is selected from the group consisting of: wherein R 8 is selected from a bond, C 1 -C 30 alkylene, C 2 -C 30 alkenylene, C 2 -C 30 alkynylene; C 1 -C 30 heteroalkylene, C 2 -C 30 heteroalkenylene, C 2 -C 30 heteroalkynylene, C 7 -C 30 heteroalkylarylene, C 8 -C 30 heteroalkenylarylene, C 8 -C 30 heteroalkynylarylene, C 7 -C 30 alkylarylene, C 8 -C 30 alkenylarylene, C 8 -C 30 alkynylarylene, and C 2 -C 30 heteroarylene; and wherein R 9 and R 10 are each independently selected from H, C 1 -C 30 alkyl, C 1 -C 30 heteroalkyl, C 2 -C 30 alkenyl, C 2 -C 30 alkynyl, C 2 -C 30 heteroalkenyl, and C 2 -C 30 heteroalkynyl. 2. A biocompatible polymer, comprising a recurring unit of formula: wherein: j and k are each independently zero or an integer selected from 1 to 6, provided that j and k are not both 0; X 1 and X 2 are each independently bromine (Br) or iodine (I), and y 1 and y 2 are each independently 0, 1, 2, 3, or 4; L 1 is selected from the group consisting of oxygen (—O—), —R 4 —C(═O)—O—, and —O—R 4a —O—C(═O)—; wherein R 4 is selected from the group consisting of C 1 -C 30 alkylene, C 2 -C 30 alkenylene, C 2 -C 30 alkynylene, C 1 -C 30 heteroalkylene, C 2 -C 30 heteroalkenylene, C 2 -C 30 heteroalkynylene, C 6 -C 30 arylene, C 7 -C 30 alkylarylene, C 5 -C 30 alkenylarylene, C 5 -C 30 alkynylarylene, and C 2 -C 30 heteroarylene; and R 4a is selected from the group consisting of C 1 -C 30 alkylene, C 2 -C 30 alkenylene, C 2 -C 30 alkynylene, C 1 -C 30 heteroalkylene, C 2 -C 30 heteroalkenylene, C 2 -C 30 heteroalkynylene, C 6 -C 30 arylene, C 7 -C 30 alkylarylene, C 5 -C 30 alkenylarylene, C 5 -C 30 alkynylarylene, and C 2 -C 30 heteroarylene; L 4 is selected from the group consisting of a bond, and optionally substituted phenoxy (—C 6 H 4 —O—); L 5 is a bond; Q 2 at each occurrence is independently hydrogen or halogen; or two adjacent Q 2 form a double bond when adjacent Qs are present; or Z 2 and an adjacent Q 2 form a double bond; Z 2 is hydrogen, —N(R x )C(═O)R 5 , —N(R x )COOR 6 , —C(O)OR 7 or —C(O)NR x R y , or Z 2 and an adjacent Q 2 form a double bond; wherein R 5 , R 6 , R 7 , R x and R y are independently at each occurrence selected from the group consisting of hydrogen, alkyl, aryl, alkylaryl, arylalkyl, heteroalkyl, and heteroalkylaryl, wherein the non-hydrogen groups contain up to 30 carbon atoms, wherein the heteroalkyl group contains from 1 to 10 heteroatoms independently selected from O, N and S, and the heteroalkylaryl group contains from 1 to 3 heteroatoms independently selected from O, N and S. 3. The biocompatible polymer of claim 1 , wherein L 1 is oxygen and L 4 is a bond, providing a recurring unit of formula: 4. The biocompatible polymer of claim 2 , wherein L 1 is oxygen and L 4 is a bond, providing a recurring unit of formula: 5. The biocompatible polymer of claim 1 , wherein L 1 is oxygen and L 4 is a bond, and Q 2 is hydrogen, providing a recurring unit of formula: 6. The biocompatible polymer of claim 2 , wherein L 1 is oxygen and L 4 is a bond, and Q 2 is hydrogen, providing a recurring unit of formula: 7. The biocompatible polymer of claim 6 , wherein the phenyl groups of the recurring unit have the phenolic oxygens in the para-position. 8. The biocompatible polymer of claim 6 , wherein L 4 is a bond, L 1 is oxygen, and Q 2 and Z 2 are both hydrogen. 9. The biocompatible polymer of claim 1 , wherein j=k=1, L 1 is oxygen, L 4 is a bond, and Q 2 and Z 2 are each hydrogen, providing a recurring unit of formula: 10. The biocompatible polymer of claim 2 , wherein j=k=1, L 1 is oxygen, L 4 is a bond, and Q 2 and Z 2 are each hydrogen, providing a recurring unit of formula: 11. The biocompatible polymer of claim 9 , wherein X 1 and X 2 are iodine, and one of y1 and y2 is non-zero. 12. The biocompatible polymer of claim 9 , wherein X 1 and X 2 are iodine, one of y1 and y2 is 2, and the phenyl groups of the recurring unit have the phenolic oxygens in the para-position. 13. The biocompatible polymer of claim 9 , which is a polycarbonate and further comprises a second recurring unit of optionally iodinated tyrosol. 14. A biocompatible polyurethane comprising an optionally iodinated tyrosine or an optionally iodinated tyrosine ester recurring unit, and a second recurring unit selected from the group consisting of HBA (hydroxybenzoic acid), mono-iodinated HBA and di-iodinated HBA. 15. A biocompatible copolymer comprising the recurring unit of the poly
containing nitrogen · CPC title
Succinic acid esters · CPC title
having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton · CPC title
Oxalic acid esters · CPC title
the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.